NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 8.45% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 5.13% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 5.09% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 4.95% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 4.89% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.4% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 4.01% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.93% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 3.79% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 3.72% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 3.52% |
| RCKT | Rocket Pharmaceuticals Inc | Healthcare | Biotechnology | 3.42% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.38% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 3.38% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.34% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.05% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 2.99% |
| MYGN | Myriad Genetics Inc | Healthcare | Diagnostics & Research | 2.94% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 2.9% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 2.69% |
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.